Which subgroup of patients with dilated cardiomyopathy would benefit from long-term beta-blocker therapy? A histologic viewpoint
- 1 March 1993
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 21 (3), 628-633
- https://doi.org/10.1016/0735-1097(93)90094-h
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Long-term (2 year) beneficial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathyJournal of the American College of Cardiology, 1991
- Effectiveness of long-term beta-blocker therapy for dilated cardiomyopathy—echocardiographical follow-upCardiovascular Drugs and Therapy, 1991
- Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol.Circulation, 1989
- Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy.Circulation, 1989
- Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial.Circulation, 1985
- A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1985
- Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy.Heart, 1980
- Beneficial effects of long-term beta-blockade in congestive cardiomyopathy.Heart, 1980
- PROLONGATION OF SURVIVAL IN CONGESTIVE CARDIOMYOPATHY BY BETA-RECEPTOR BLOCKADEThe Lancet, 1979
- Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.Heart, 1975